ADC THERAPEUTICS SA (ADCT:NYSE)
$3.74 -0.02 (-0.5319%)
Analysed ADC THERAPEUTICS SA (ADCT:NYSE) News Sources
ADC Therapeutics Announces New Employee Inducement Grant
01-04-2026
yahoo.com
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
30-03-2026
yahoo.com
ADC Therapeutics Eyes ZYNLONTA Expansion as LOTIS-5 Data Nears at H.C. Wainwright Chat
27-03-2026
marketbeat.com
ADC Therapeutics (ADCT) Reports 2025 Revenue of $73.6M With Cash Runway Into 2028
18-03-2026
yahoo.com
Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?
13-03-2026
yahoo.com
ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
10-03-2026
yahoo.com
ADC Therapeutics Q4 Earnings Call Highlights
10-03-2026
marketbeat.com
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
10-03-2026
yahoo.com
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
10-03-2026
yahoo.com
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
03-03-2026
yahoo.com
What is the current price of ADC THERAPEUTICS SA (ADCT:NYSE)?
The current price of ADC THERAPEUTICS SA (ADCT:NYSE) is $3.74.
ADC THERAPEUTICS SA (ADCT:NYSE) absolute price change since previous trading day?
The absolute price change of ADC THERAPEUTICS SA (ADCT:NYSE) since the previous trading day is $-0.02.
ADC THERAPEUTICS SA (ADCT:NYSE) percentage price change since previous trading day?
The percentage price change of ADC THERAPEUTICS SA (ADCT:NYSE) since the previous trading day is -0.5319%.
What is the most recent average sentiment score for ADC THERAPEUTICS SA (ADCT:NYSE)?
The most recent average sentiment score for ADC THERAPEUTICS SA (ADCT:NYSE) is 82 out of 100.
What is the most recent average sentiment for ADC THERAPEUTICS SA (ADCT:NYSE)?
The most recent sentiment for ADC THERAPEUTICS SA (ADCT:NYSE) is .
SEC-8K** Filing Available For ADC THERAPEUTICS SA (ADCT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.